These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 19170854

  • 41. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
    Carrier S, Brock GB, Pommerville PJ, Shin J, Anglin G, Whitaker S, Beasley CM.
    J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report.
    Liguori G, Trombetta C, De Giorgi G, Pomara G, Maio G, Vecchio D, Ocello G, Ollandini G, Bucci S, Belgrano E.
    J Sex Med; 2009 Feb; 6(2):544-52. PubMed ID: 19138360
    [Abstract] [Full Text] [Related]

  • 43. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, Park K, Paick JS, Dyachkova Y, Dwight T, Lee MS.
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [Abstract] [Full Text] [Related]

  • 44. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L, Slagter C, Slob AK, Hop WC.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):439-44. PubMed ID: 16965992
    [Abstract] [Full Text] [Related]

  • 45. [Benefits of tadalafil to ED patients].
    Zhao LM, Jiang H, Hong K, Liu DF, Ma LL, Zhu JC.
    Zhonghua Nan Ke Xue; 2011 Jan 01; 17(1):89-92. PubMed ID: 21351538
    [Abstract] [Full Text] [Related]

  • 46. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
    Jones LA, Klimberg IW, McMurray JG, Padula R, Tseng LJ, Stecher VJ.
    J Sex Med; 2008 Aug 01; 5(8):1955-64. PubMed ID: 18564150
    [Abstract] [Full Text] [Related]

  • 47. The role of initial success rates and other factors in determining reliability of outcomes of phosphodiesterase inhibitor therapy for erectile dysfunction: a pooled analysis of 17 placebo-controlled trials of tadalafil for use as needed.
    Sontag A, Rosen RC, Litman HJ, Ni X, Araujo AB.
    J Sex Med; 2013 Feb 01; 10(2):541-50. PubMed ID: 22905853
    [Abstract] [Full Text] [Related]

  • 48. [Tadalafil and patients preference in the treatment of erectile dysfunction].
    Hu JL, Chen B.
    Zhonghua Nan Ke Xue; 2006 Dec 01; 12(12):1145-8. PubMed ID: 17201266
    [Abstract] [Full Text] [Related]

  • 49. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis.
    Lombardi G, Macchiarella A, Del Popolo G.
    J Sex Med; 2010 Jun 01; 7(6):2192-2200. PubMed ID: 20384939
    [Abstract] [Full Text] [Related]

  • 50. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A, Shen W, Whitaker JS.
    Eur Urol; 2006 Aug 01; 50(2):351-9. PubMed ID: 16766116
    [Abstract] [Full Text] [Related]

  • 51. Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies.
    Paduch DA, Bolyakov A, Polzer PK, Watts SD.
    BJU Int; 2013 Feb 01; 111(2):334-43. PubMed ID: 23356749
    [Abstract] [Full Text] [Related]

  • 52. Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors.
    Althof SE, Buvat J, Gutkin SW, Belger M, Stothard DR, Fugl-Meyer AR.
    J Sex Med; 2010 Jan 01; 7(1 Pt 1):203-15. PubMed ID: 19845846
    [Abstract] [Full Text] [Related]

  • 53. Psychosocial impact and effectiveness of tadalafil among treatment-naïve and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries.
    El Khiat Y, Ghazi S, Allam A, Khawaja M, Belger M, Tamer M, Kopernicky V.
    Curr Med Res Opin; 2008 Jul 01; 24(7):1965-73. PubMed ID: 18547465
    [Abstract] [Full Text] [Related]

  • 54. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study.
    Chevret-Méasson M, Lavallée E, Troy S, Arnould B, Oudin S, Cuzin B.
    J Sex Med; 2009 Mar 01; 6(3):761-9. PubMed ID: 19143916
    [Abstract] [Full Text] [Related]

  • 55. [Observation of safety and efficacy of tadalafil for men with erectile dysfunction].
    Zhu XW, Li FY, Fang JJ.
    Zhonghua Nan Ke Xue; 2006 May 01; 12(5):421-3, 427. PubMed ID: 16755872
    [Abstract] [Full Text] [Related]

  • 56. Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.
    Nagao K, Kimoto Y, Marumo K, Tsujimura A, Vail GM, Watts S, Ishii N, Kamidono S.
    Urology; 2006 Oct 01; 68(4):845-51. PubMed ID: 17070365
    [Abstract] [Full Text] [Related]

  • 57. Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies.
    Mirone V, Fusco F, Rossi A, Sicuteri R, Montorsi F.
    BJU Int; 2009 May 01; 103(9):1212-7. PubMed ID: 19154480
    [Abstract] [Full Text] [Related]

  • 58. Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation.
    Althof SE, Rubio-Aurioles E, Kingsberg S, Zeigler H, Wong DG, Burns P.
    Urology; 2010 Jun 01; 75(6):1358-63. PubMed ID: 20206967
    [Abstract] [Full Text] [Related]

  • 59. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB, Auerbach S, Roehrborn CG, Costa P, Garza MS, Esler AL, Wong DG, Secrest RJ.
    J Sex Med; 2012 Jan 01; 9(1):271-81. PubMed ID: 21981682
    [Abstract] [Full Text] [Related]

  • 60. Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study.
    Buvat J, Hatzichristou D, Boess FG, Büttner H, Gehchan N, Henneges C, Porst H.
    Int J Clin Pract; 2014 Sep 01; 68(9):1087-99. PubMed ID: 25123817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.